Manufactured Object
Merck Q3 2025: Solid Organic Growth Across All Sectors
Merck; Q3 2025; Organic growth; KEYTRUDA; Oncology; Animal Health; Verona Pharma acquisition; Gross margin; Revenue; New product launches
From Weight Loss to Hair Loss: The Search for the Next Blockbuster – Recent Developments and News (2024-2025)
weight loss drugs; GLP-1; hair loss treatments; Pelage Pharmaceuticals; Veradermics; blockbuster drugs; pattern hair loss; baldness cure; minoxidil; PP405; androgenetic alopecia; biotech investment
Eisai Expands Leqembi Subcutaneous Label, Accelerates Early U.S. Launch Progress for Alzheimer’s Disease
Eisai; Leqembi; subcutaneous autoinjector; label expansion; Supplemental Biologics License Application (sBLA); FDA; maintenance dosing; starting dose; early Alzheimer’s disease; at-home injection; launch progress
Eli Lilly to Invest $3 Billion in New European Factory for Weight-Loss Pill Orforglipron
Eli Lilly; Orforglipron; obesity pill; Leiden Bio Science Park; Netherlands; GLP-1 receptor agonist; manufacturing facility; European market; advanced manufacturing; global supply chain
Spotlight On: VC Deal Flow – October’s Haul Sets 2025 up to Run Rings Around Previous Year
Venture Capital; Deal Flow; 2025; October Funding; AI investment; Megadeals; Exit activity; TMT sector; Funding rounds; Unicorn births
Lilly Commits $1.2 Billion to Expand GLP-1 Pill Manufacturing Facility in Puerto Rico
Eli Lilly; Puerto Rico; GLP-1 receptor agonist; orforglipron; manufacturing expansion; oral medicines; investment; Carolina; pharmaceutical production; U.S. supply chain
United Imaging Healthcare Q3 2025 Results: Overseas Revenue Up 42% YoY
United Imaging Healthcare; Q3 2025 results; overseas revenue growth; medical imaging; emerging markets; R&D investment; global expansion
Cytek Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Cytek Biosciences; flow cytometry; access expansion; ISAC collaboration; instrument awards; research grants; Full Spectrum Profiling (FSP); European expansion; Amsterdam facility; cell analysis
Eli Lilly and Nvidia to Build Pharma’s Largest AI Supercomputer for Drug Discovery
Eli Lilly; Nvidia; supercomputer; AI; drug discovery; Blackwell Ultra GPU; clinical trials; biomedical foundation models; pharmaceutical industry; high-performance computing
Expert Insights to Navigate Your CGT Challenges: Recent Updates and Strategic Guidance for 2025
capital gains tax; CGT challenges; 2025 tax rates; long-term capital gains; tax planning; tax minimization strategies; Net Investment Income Tax; private equity tax changes